Artificial intelligence is being incorporated into more places in healthcare, for uses such as guiding clinical trial enrollment as well as helping physicians get up to speed on a patient's history. A panel discussed these applications and more during MedCity News's INVEST conference in Chicago.
In this episode of the MedCity Pivot Podcast, editor-in-chief Arundhati Parmar, speaks with Helix CEO James Lu about his company and how far precision medicine has come.
Inaccurate provider data is creating a hidden crisis in healthcare by delaying care and driving up costs for both patients and health plans, according to CAQH CEO Sarah Ahmad. Her organization is working to address the issue by improving how provider data is collected and verified on the front end.
As real-time inference overtakes training-centric approaches, a pivotal question emerges: how can the human element remain central in an increasingly autonomous ecosystem?
While prior authorization has made many headlines over the past year, concurrent review has not. Yet missteps in both processes leave hospitals in danger of not getting paid, which can result in higher costs being passed down to patients.
Nowadays, there is much discussion about innovation and the role technology can play to improve the healthcare industry — but one expert is frustrated by the lack of movement in the prior authorization space.
Jesse Ehrenfeld, immediate past president of the American Medical Association, pointed this out at MedCity News' INVEST conference in Chicago. The AMA has dedicated a lot of time and effort to working with payers and providers to establish a set of consensus guidelines for what the prior authorization process should look like — but payers aren't really coming to the table to make the necessary changes, Ehrenfeld said.
"Got thrown out the window, completely ignored by the payer community," he stated.
No comments